Fivos Papamalis

Clinical Practitioner

Ταλέντο

Thessaloníki, Dimos Thessaloniki, Θεσσαλονίκη0Μέλος από 31 Οκτωβρίου 2024

Προσλάβετε αυτό το άτομο

Στείλτε μια αγγελία εργασίας απευθείας σε αυτόν/αυτήν τον υποψήφιο/α

Σχετικά

Dr. Papamalis has extensive experience as a senior advisor and scientific consultant at (inter) governmental and non-governmental bodies in country and abroad. He has served as a member of various advisory boards, EU Expert Groups and scientific committees.

As an advisor to the National Drug Coordinator Office of Greece (2014-17) at the Ministry of Administrative Reform and e-Governance, he contributed to the development of the Greek National Drug Strategy 2014 -2020 and National Action Plan 2014-2016, provided scientific consultations and designed materials for strategic upgrade on issues related to national drug policy and on demand and supply reduction strategies. Guided the development of inter-sectoral coordination mechanisms and proposed best practice model of care across Greek health system, early intervention and intelligent let crime prevention strategies. As a senior expert at the Policy and Legal Advice Centre, he assessed the transposition of EU Regulations in the Serbian legal order and provided recommendations for the harmonization of the national Drug Law with the EU acquis and the UN conventions.

Following desk based review and screening reports for Serbia for Chapters 24, 28, 29 and 23, consultation with Serbian stakeholders including the Ministry of Health, Assistant Minister and the Head of the monitoring system, national focal point of the EMCDDA; Ministry of Interior - Deputy Head of Department for Smuggling Suppression of Synthetic Drugs and Abuse Prevention at Criminal Investigations and Drugs Trafficking Suppression; Director for combating Organized Crime; Director of the Government Office for Combating Drugs; Anti-smuggling department - Custom Administration of Serbia (CAS); Ministry of Finance, Customs affairs and customs procedures division; Ministry of Agriculture and Environmental Protection and other relevant key institution, he performed legal gap analysis of the level of compliance of Serbian Law with EU legislation in the area of drug abuse prevention and trade in drug precursors - state of play and perspective and provided a set of recommendations in order to facilitate the harmonization process.During his time at the Ministry he reviewed current practices and policies, assessed the national Science, technology and innovation (STI) systems in order to ensure shared responsibility, participatory forms of governance and a framework for evidence-based policy formulations. He also designed policy recommendations for implementation of contemporary approaches in the penal system promoting therapeutic justice principles and improvement of the legal framework for social inclusion, anti-discrimination legislation, alternatives to incarceration and implementation of human rights-oriented policies. During the Hellenic Precedency of the Council of the European Union (2015), as an Expert on demand reduction issues and Assistant on External Affairs he edited and drafted the EU (regulation on New Psychoactive Substances) and UN resolutions (L13, L14) submitted by Greece on behalf of the EU.

He chaired the informal consultations between EU and other UN Member States and successfully coordinated various bilateral and multilateral discussions and negotiations and successfully developed several policy and scientific reports. He demonstrated the ability to work effectively under pressure in a highly political environment, as well as advanced negotiation and problems solving skills. His contribution to the political dialogs with the third countries and his participation on High-Level Meetings, such as the Coordination and Cooperation Mechanism between the EU and CELAC, provided him a valuable experience and protocol awareness of the EU and the UN core functions and mandates.As a research consultant (2016 -17) at the Council of Europe, Pompidou Group - Co-operation Group to Combat Drug Abuse and Illicit Trafficking, he examined and developed a report on the potential adverse effects and associated cost of drug control policies in the EU.

Reviewed the translational research on scientific academic and policy literature to address best practices on policy- research gaps. As member of several EU Expert Groups i.e. on EU minimum quality standards or on International policies and the respect of Human Rirhts increased his abilities to work independently, take initiatives and providing strategic input that influence and stimulates the policy research agenda, he developed awareness of the importance of the legal ethical and security requirements involved in data management and developed new techniques for knowledge management and stanslation of research findings in practice.

Dr. Papamalis has extensive direct experience in translational research to policy projects based on modified version of the Consolidate Framework for Implementation Research (CFIR), that has been successfully utilised on enhancing compatibility of national legislation with EU legislation and its effective implementation. More specifically, he has management experience in all phases of the process of negotiations and on facilitating competent authorities’preparedness for the transposition process, inter alia, necessary by-laws, regulatory instruments and/or other complementary measures that will facilitate adequate implementation and enforcement practices.

Adopting a sequential process from pre-intervention phase (needs assessment; situation/stakeholder analysis; compatibility- compliance check); to identify harmonisation challenges, practice gaps and ‘mapping’ hotspots (legal analysis, policy mapping) to assess existing resource allocations schemes, decision making, rules of procedures, cross-cutting themes and systemic weakness) that informs the next phase; triangulating data collection the findings are communicated in a participatory manner with the relevant stakeholders to set the grounds for the final Implementation/dissemination phase that involves intelligent -led transposition strategies, advanced diplomatic and horizontal negation tactics and documentation reporting, pre‐accession strategy; and implementation procedures.

Εμπειρία

Translational research – implementation research framework

Dr. Papamalis has been engaged in numerous inter-disciplinary groups and translational related projects such as research consultant at the Norwegian Ministry of Health and the Norwegian Institute of Public Health (2015-16) for examining drug public expenditures and provide evidence for efficient recourse relocation as well as formulating policy guidelines based on multileveled conceptualization of policy- use - harm nexus. As project coordinator at the Serbian Ministry of Health (2004) he designed a project on strengthening inter-sectoral linkages among CSOs, stale-led institution and academia by increasing their capacity and skills to implement community-based interventions and development of integrated research and monitoring tools.

As a consultant at the International Harm Reduction Association (2016) he investigated the current state of the financial investment and implementation of evidence-based harm reduction interventions and resource allocation of Harm Reduction in Greece. Due to his valuable contribution and experience on translational research. During the period 2015-20 he was invited in several informal expert meetings in Greece to provide consultation to the Greek Government on social challenges

Dr. Papamalis is nominated on several EU interdisciplinary expert groups and actively engaged on regional and international research networks (EWODOR, Global Addiction, EUROPAD, SEEAN), which provided him a unique opportunity for cross-fertilization between disciplines and build mutually innovative synergies that bridge the gap between research and practice. He actively collaborates with several research centres and governmental institutions in the region.

Member of professional organization and Expert Groups

Member of the Scientific Advisory Group for the EU Harm Reduction Investment (2016)
Member of the Pompidou Expert group of the Council of Europe on the Possible adverse effects and associated cost of drug control policies (2015 -2016)
Member of the Expert Working Group for the definition of EU Minimum Quality Standards in Demand Reduction (2014- 2015)
Member of the EU Expert Working Group on International drug policy and the respect of human rights (including availability of medicines, abolition of death penalty, alternatives to incarceration, civil society involvement in drug policy making and implementation, etc.) (2014)
Member of the European Working Group On Drugs Oriented Research
Member of the EU Expert Working Group on Enhancing public health approach, based on scientific evidence-based interventions and best practices: prevention; treatment; risk and harm reduction, recovery, social reintegration and rehabilitation (2014)
Full Associate of the International Academy of Investigative Psychology (2013-2014)
International Affiliate member of APA (American Psychological Association) (2013-2015)
Member of the Society of Addiction Psychology (2013-2016)
Member of the European Association of Personality Psychology (2012-2015)
Member of the Global Addiction Association (2013-2016)
Member of the European Working Group On Drugs Oriented Research (2012–2016)
Since 2015 a reviewer at the International Journal of Drug Policy. Received a Certificate of Reviewing (2015) in recognition of the review made for the Journal – International Journal of Drug Policy

Attendance at Expert Groups and professional meetings related to my research interests

Participation on the 1st Harm Reduction Works Project at the EMCDDA (Lisbon 2016)
Participation on the 4th meeting of the Expert group on the Effects and associated costs of drug control policies (Reykjavik, May 2016)
Participation on the 3rd meeting of the Expert group on the Effects and associated costs of drug control policies (Paris, January 2016)
Participation on the 2nd meeting of the Pompidou Group Expert group on the Effects and associated costs of drug control policies (Jerusalem, September, 2015)
Participation on the 1st meeting of the Pompidou Group Expert group on the Effects and associated costs of drug control policies (Oslo, June, 2015)
Coordination and representation of the European Union at the 57th Session of the Commission on Narcotic Drugs (CND) of the United Nations (Vienna, 2015)
Participation on the negotiations and drafting of the political declaration between the European Union and the Community of Latin America and Caribbean States (CELAC) (Vienna, 2015)
Participation at the political dialogue with the third countries, such as the Western Balkans countries, Latin America, USA, Canada, Uruguay. (Brussels, 2015)
Research coordinator at the Global Drug Survey (GDS) for Greece in 2015
Participation on the Scientific consultations among diverse stakeholders and policy makers on issues related to National Drug Policy on demand and supply reduction strategies (Athens, 2014)
Participation on the discussions and negotiations of the supply and demand reduction national committees, and reached consensus on the joint development of the National Action Plan and Drug Strategy 2014-2016. (Athens, 2014)
Project associate & coordinator for Serbia for the International Narrative Experience of Offending Project (Serbia, 2013)
Participation at the Expert Joint meeting UNODC -Drug policy Network SEE (Vienna, 2012)
Founder and Director of SENSE - Southeast European Network of Social Empowerment (2011)

Εκπαίδευση

-Project development, documentation and reporting tasks

Coordinate research projects

-Prepare research manuscripts and research presentations

Conduct quality control processes and online evaluations of EU projects
Develop and prepare materials for EU projects

-Prepare analytical reports relative to research data.

-Monitor progress of research projects and coordinates information between departmental sections. -Perform a wide and complex variety of assays, test, and studies.